CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Venatorx Pharmaceuticals of Malvern, Pennsylvania, yesterday released promising data from a phase 3 trial of its investigational new drug for patients with complicated urinary tract infections (cUTIs).
In the US, lawmakers scramble to find funding for COVID-19 activities.
Delaware, Maryland, and Missouri report new highly pathogenic avian flu outbreaks.
Protection against hospital illness was 85% for 2 doses against Alpha and Delta and 86% for 3 doses against Omicron.
The absolute difference between an antiseptic drug and antibiotics has limited clinical significance.
While Medicare beneficiary hospitalizations for non–COVID-19 diagnoses fell sharply in March and April 2020 and stayed low through September 2021, death rates after hospitalization rose substantially—particularly for Black and Hispanic patients, finds a study yesterday in JAMA Network Open.
A study of children 3 years old or younger who were hospitalized for uncomplicated community-associated pneumonia (CAP) found that a significant proportion did well without a full course of antibiotics, researchers reported yesterday in Open Forum Infectious Diseases.
"These findings imply that the pandemic may substantially contribute to the world dementia burden."
The United States continues to report the most COVID-19 fatalities of any country.
Continuing the corticosteroid dexamethasone after hospital release didn't benefit COVID-19 patients who didn't complete the 10-day drug regimen during their stay, finds a study published yesterday in JAMA Network Open.
Fully 92% of side effects during the first 6 months of the US vaccine rollout were mild and short-lived.
Different approaches may be needed in the future, experts say, such as vaccines that target a specific variant.
The imaging differences between COVID-19 and non-COVID patients were modest, about 2%.
China has reported to more H5N6 avian flu infections in humans, both fatal in people who were sick in November and died in early December, Hong Kong's Centre for Health Protection (CHP) said in a statement today.
Three percent of 10,403 adults with COVID-19 pneumonia were diagnosed as having new-onset dementia after a median of 182 days, a significantly higher proportion than that observed with other types of pneumonia, finds a study yesterday in Open Forum Infectious Diseases.
Social determinants of health tied to COVID-19 death rates vary by race and community type, a new study finds.
The roadmap advises against school closings, lobbies for more tests, and details when restrictions should lift.
The CDC says the risk to humans is low, but people with elevated exposure may be at higher risk.
Concerns are growing that continued spread could create COVID-19 virus reservoirs in animals.
A new joint report on antimicrobial resistance (AMR) in European Union/European Economic Activity (EU/EEA) countries is calling for concerted action to address the problem from a One Health perspective.
